Mechanistically, melatonin upregulates the core clock protein BMAL1, which transcriptionally represses its downstream target ALDH3A1, thereby effectively blocking the glycolytic program in tumor cells and suppressing cancer progression. Here, ALDH3A1 is linked to cancer.